4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease
- 1 August 1999
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 354 (9178), 556-560
- https://doi.org/10.1016/s0140-6736(99)02220-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Randomized, Placebo‐Controlled Trial of HA‐1A, a Human Monoclonal Antibody to Endotoxin, in Children with Meningococcal Septic ShockClinical Infectious Diseases, 1999
- The Relationship between Plasminogen Activator Inhibitor-1 and Proinflammatory and Counterinflammatory Mediators in Children with Meningococcal Septic ShockThe Journal of Infectious Diseases, 1996
- The role of hemolymph coagulation in innate immunityCurrent Opinion in Immunology, 1996
- The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminansThe Pediatric Infectious Disease Journal, 1994
- Deficiency of prostacyclin production in meningococcal shock.Archives of Disease in Childhood, 1991
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989
- The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.The Journal of Experimental Medicine, 1989
- Elastase-α1-proteinase inhibitor: An early indicator of septicemia and bacterial meningitis in childrenThe Journal of Pediatrics, 1987
- Purpura Fulminans in Meningococcemia: Association with Acquired Deficiencies of Proteins C and SNew England Journal of Medicine, 1987
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.JCI Insight, 1987